Economic Impact of Dementia After Kidney Transplantation: A Matched Cohort Analysis

Fuente: Wiley Open Access
Guardado en:
Detalles Bibliográficos
Autores principales: Krista L. Lentine, Melissa L. Swee, Wisit Cheungpasitporn, Huiling Xiao, Yasar Caliskan, Mara McAdams‐DeMarco, Yusi Chen, Sunjae Bae, Dorry Segev, David Axelrod, Mark Schnitzler
Formato: Artículo Open Access
Publicado: Wiley 2025
Materias:
Acceso en línea:
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
_version_ 1867003364917641216
author Krista L. Lentine
Melissa L. Swee
Wisit Cheungpasitporn
Huiling Xiao
Yasar Caliskan
Mara McAdams‐DeMarco
Yusi Chen
Sunjae Bae
Dorry Segev
David Axelrod
Mark Schnitzler
author_facet Krista L. Lentine
Melissa L. Swee
Wisit Cheungpasitporn
Huiling Xiao
Yasar Caliskan
Mara McAdams‐DeMarco
Yusi Chen
Sunjae Bae
Dorry Segev
David Axelrod
Mark Schnitzler
Krista L. Lentine
Melissa L. Swee
Wisit Cheungpasitporn
Huiling Xiao
Yasar Caliskan
Mara McAdams‐DeMarco
Yusi Chen
Sunjae Bae
Dorry Segev
David Axelrod
Mark Schnitzler
collection Wiley Open Access
contents Economic Impact of Dementia After Kidney Transplantation: A Matched Cohort Analysis Krista L. Lentine Melissa L. Swee Wisit Cheungpasitporn Huiling Xiao Yasar Caliskan Mara McAdams‐DeMarco Yusi Chen Sunjae Bae Dorry Segev David Axelrod Mark Schnitzler Clinical Transplantation ABSTRACT Background Kidney disease significantly increases the risk of dementia, including among kidney transplant (KTx) recipients. To date, the cost implications of dementia after KTx are not well described. Methods We performed a retrospective cohort study of US Renal Data System (USRDS) data (2006–2020) to estimate cost of care for ≥65‐year‐old Medicare insured KTx recipients (2006–2020) with newly diagnosed dementia ( n  = 3285), compared to propensity‐matched controls without dementia ( n  = 6570). KTx recipients age 65+ years with post‐KTx dementia were identified by diagnosis codes, and costs were computed based on payments on Medicare claims. Average costs per month, marginal costs per month, and cumulative costs were compared after dementia diagnosis versus after the equivalent time post‐KTx in controls. Results Dementia was diagnosed at a mean of 5.1 ± 3.4 years post‐KTx. Patients' characteristics were well matched in cases versus controls, including age (mean: 70.1 vs. 69.9 years), sex (38.4% vs. 37.9% women), race (23.7% vs. 22.2% African American), and cause of ESKD (45.4% vs. 43.7% diabetes). Over 4 years post‐KTx, dementia was associated with reduced survival (27% vs. 68%) along with $66 145 (95% CI $51 560‐$78 489) higher Medicare spending. Average monthly costs in dementia patients reached a maximum of $12 713 and exceeded the cost of unaffected patients by up to $9789 per month. Conclusions Post‐KTx dementia dramatically increased resource utilization and reduced post‐KTx surivival. These findings highlight the need for care pathways that better integrate cognitive health assessment and management into the care of KTx candidates and recipients. 10.1111/ctr.70189 http://onlinelibrary.wiley.com/termsAndConditions#vor
doi_str_mv 10.1111/ctr.70189
format Artículo Open Access
id wiley_oa_10_1111_ctr_70189
institution Wiley Open Access
license_str_mv http://onlinelibrary.wiley.com/termsAndConditions#vor
publishDate 2025
publisher Wiley
record_format wiley_oa
spellingShingle Economic Impact of Dementia After Kidney Transplantation: A Matched Cohort Analysis
Krista L. Lentine
Melissa L. Swee
Wisit Cheungpasitporn
Huiling Xiao
Yasar Caliskan
Mara McAdams‐DeMarco
Yusi Chen
Sunjae Bae
Dorry Segev
David Axelrod
Mark Schnitzler
Clinical Transplantation
Economic Impact of Dementia After Kidney Transplantation: A Matched Cohort Analysis Krista L. Lentine Melissa L. Swee Wisit Cheungpasitporn Huiling Xiao Yasar Caliskan Mara McAdams‐DeMarco Yusi Chen Sunjae Bae Dorry Segev David Axelrod Mark Schnitzler Clinical Transplantation ABSTRACT Background Kidney disease significantly increases the risk of dementia, including among kidney transplant (KTx) recipients. To date, the cost implications of dementia after KTx are not well described. Methods We performed a retrospective cohort study of US Renal Data System (USRDS) data (2006–2020) to estimate cost of care for ≥65‐year‐old Medicare insured KTx recipients (2006–2020) with newly diagnosed dementia ( n  = 3285), compared to propensity‐matched controls without dementia ( n  = 6570). KTx recipients age 65+ years with post‐KTx dementia were identified by diagnosis codes, and costs were computed based on payments on Medicare claims. Average costs per month, marginal costs per month, and cumulative costs were compared after dementia diagnosis versus after the equivalent time post‐KTx in controls. Results Dementia was diagnosed at a mean of 5.1 ± 3.4 years post‐KTx. Patients' characteristics were well matched in cases versus controls, including age (mean: 70.1 vs. 69.9 years), sex (38.4% vs. 37.9% women), race (23.7% vs. 22.2% African American), and cause of ESKD (45.4% vs. 43.7% diabetes). Over 4 years post‐KTx, dementia was associated with reduced survival (27% vs. 68%) along with $66 145 (95% CI $51 560‐$78 489) higher Medicare spending. Average monthly costs in dementia patients reached a maximum of $12 713 and exceeded the cost of unaffected patients by up to $9789 per month. Conclusions Post‐KTx dementia dramatically increased resource utilization and reduced post‐KTx surivival. These findings highlight the need for care pathways that better integrate cognitive health assessment and management into the care of KTx candidates and recipients. 10.1111/ctr.70189 http://onlinelibrary.wiley.com/termsAndConditions#vor
title Economic Impact of Dementia After Kidney Transplantation: A Matched Cohort Analysis
topic Clinical Transplantation
url https://onlinelibrary.wiley.com/doi/10.1111/ctr.70189